X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (182) 182
Book Review (29) 29
Conference Proceeding (21) 21
Publication (14) 14
Book / eBook (8) 8
Newspaper Article (8) 8
Web Resource (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (85) 85
index medicus (75) 75
humans (67) 67
female (60) 60
breast cancer (54) 54
breast neoplasms - drug therapy (38) 38
breast neoplasms - pathology (35) 35
middle aged (35) 35
chemotherapy (33) 33
trastuzumab (32) 32
aged (30) 30
adult (29) 29
cancer (22) 22
metastasis (21) 21
care and treatment (20) 20
treatment outcome (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
survival (18) 18
breast neoplasms - mortality (17) 17
therapy (16) 16
women (16) 16
breast neoplasms - metabolism (15) 15
cancer therapies (15) 15
disease-free survival (15) 15
antineoplastic agents - therapeutic use (14) 14
lapatinib (14) 14
skin and connective tissue diseases (14) 14
tumors (14) 14
antineoplastic agents (13) 13
neoplasm staging (13) 13
research (13) 13
aged, 80 and over (12) 12
combination (12) 12
hematology, oncology and palliative medicine (12) 12
metastatic breast cancer (12) 12
neoplasm metastasis (12) 12
patients (12) 12
receptor, erbb-2 - metabolism (12) 12
animals (11) 11
breast neoplasms - genetics (11) 11
drug therapy (11) 11
pertuzumab (11) 11
receptor, erbb-2 - analysis (11) 11
antimitotic agents (10) 10
article (10) 10
breast neoplasms - chemistry (10) 10
clinical trials (10) 10
epidermal growth factor (10) 10
paclitaxel (10) 10
trial (10) 10
capecitabine (9) 9
endocrine therapy (9) 9
medicine & public health (9) 9
neoplasms (9) 9
receptor, erbb-2 - antagonists & inhibitors (9) 9
resistance (9) 9
abridged index medicus (8) 8
antibodies, monoclonal, humanized - administration & dosage (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
cell line, tumor (8) 8
docetaxel (8) 8
efficacy (8) 8
everolimus (8) 8
her2 (8) 8
kaplan-meier estimate (8) 8
adjuvant chemotherapy (7) 7
chemotherapy, adjuvant (7) 7
dose-response relationship, drug (7) 7
double-blind (7) 7
drug administration schedule (7) 7
erbb-2 protein (7) 7
mice (7) 7
monoclonal-antibody (7) 7
open-label (7) 7
paclitaxel - administration & dosage (7) 7
plus (7) 7
quality-of-life (7) 7
safety (7) 7
studies (7) 7
survival analysis (7) 7
t-dm1 (7) 7
antibodies, monoclonal - therapeutic use (6) 6
antibodies, monoclonal, humanized - therapeutic use (6) 6
bevacizumab (6) 6
brain metastases (6) 6
disease progression (6) 6
double-blind method (6) 6
fulvestrant (6) 6
immunotherapy (6) 6
judaism (6) 6
male (6) 6
maytansine - analogs & derivatives (6) 6
medicine, general & internal (6) 6
phase-ii (6) 6
prognosis (6) 6
progression (6) 6
proportional hazards models (6) 6
receptor (6) 6
receptor, erbb-2 - genetics (6) 6
risk assessment (6) 6
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Online Resources - Online (2) 2
Scarborough Hospital - Birchmount (1) 1
St. Augustine's Seminary - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Reference Desk (1) 1
Victoria University E.J. Pratt - Reference (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2006, Encyclopedia of world religions, ISBN 0816054576, xxxvi, 602
Book
07/2018, ISBN 0323581226, 265
eBook
The Lancet, ISSN 0140-6736, 06/2019, Volume 393, Issue 10191, pp. 2565 - 2567
The selection of optimal systemic therapy for early HER2-positive breast cancer has become exceedingly complex. Since the advent of adjuvant trastuzumab,... 
WOMEN | MEDICINE, GENERAL & INTERNAL | MULTICENTER | SAFETY | OPEN-LABEL | COMBINATION | PERTUZUMAB | HER2-POSITIVE BREAST-CANCER | PLUS TRASTUZUMAB | CHEMOTHERAPY | Studies | Chemotherapy | Breast cancer | ErbB-2 protein | Trastuzumab | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet, ISSN 0140-6736, 04/2019, Volume 393, Issue 10179, pp. 1390 - 1392
The remaining 18 625 patients did not have HER2 testing; thus, no HER2-directed therapy would have been given. [...]the majority of patients with HER2-positive... 
TRIAL | MEDICINE, GENERAL & INTERNAL | CYCLOPHOSPHAMIDE | Profiling | Risk groups | Mortality | Health risks | Breast cancer | Taxane | Gene expression | Cancer therapies | Patients | ErbB-2 protein | Nodes | Amplification | Chemotherapy | Hypotheses | Anthracycline | Womens health | Drug dosages | Cancer | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2019, Volume 37, Issue 13, pp. 1044 - 1044
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e12049 - e12049
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2018, Volume 24, Issue 11, pp. 2493 - 2504
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 10/2015, Volume 12, Issue 10, pp. 567 - 568
Journal Article
Oncology Times, ISSN 0276-2234, 08/2018, Volume 40, Issue 16, pp. 20 - 21
Journal Article
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, ISSN 2212-4403, 07/2019, Volume 128, Issue 1, pp. e26 - e26
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 816 - 829
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e18196 - e18196
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2018, Volume 379, Issue 8, pp. 753 - 763
Journal Article
NATURE REVIEWS CLINICAL ONCOLOGY, ISSN 1759-4774, 10/2015, Volume 12, Issue 10, pp. 567 - 568
On the basis of an Early Breast Cancer Trialists' Collaborative Group meta-analysis, it has been suggested that the controversy over post-mastectomy... 
BREAST-CANCER | MASTECTOMY | SURVIVAL | SURGERY | METAANALYSIS | RANDOMIZED-TRIALS | TRASTUZUMAB | ONCOLOGY | RECEPTOR | LOCOREGIONAL RECURRENCE | CHEMOTHERAPY | Care and treatment | Patient outcomes | Oncology, Experimental | Mastectomy | Breast cancer | Research | Radiotherapy | Methods | Cancer
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 6/2018, Volume 24, Issue 11, pp. 2493 - 2504
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.